Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials
Crossref DOI link:
Update policy: https://doi.org/10.1007/SPRINGER_CROSSMARK_POLICY
Tensfeldt, Thomas G.
Gómez-Reino, Juan J.
Funding for this research was provided by:
The article was funded by Pfizer Inc